视频标题

SSY Group Limited

Provide sufficient momentum and innovation gene for building an enterprise exceeding 10 billion

Focusing on the international development, aiming at the research and development frontier of new chemical drugs, SSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.

Drug Research Institute of SSY Group Limited covers a total area of over 56,600 ㎡, with a construction area of more than 50,000 ㎡ and a fixed asset investment of more than 500 million RMB, including 200 million RMB of laboratory instruments and equipment. It has HPLC/UPLC, gas chromatograph, thermo ion chromatograph, Fourier Infrared spectrometer, X-ray diffractometer, brookraman spectrometer, Malvin particle size meter,ultra-high speed centrifuge, Agilent dissolution apparatus, PE differential scanning calorimeter, Agilent ICP-MS, GC-MS/MS, AB LC-MS/MS, Jena atomic absorption spectrophotometer and other advanced instruments and equipment.

  • 85

    Mu

    Total floor area

  • 50000

    Building area

  • 500

    million

    Investment in fixed assets

  • 200

    million

    Instrument and equipment

Innovation, openness, inclusiveness and sharing

It has created a world-class R&D and innovation platform

Research Unit Undertaking a Sub-project of the National Major Science and Technology Special Project for New Drug Development
Research Unit Undertaking a Sub-project of the National Major Science and Technology Special Project for New Drug Development
National-Local Joint Engineering Laboratory
National-Local Joint Engineering Laboratory
National Enterprise Technology Center
National Enterprise Technology Center
National Demonstration Enterprise for Technological Innovation
National Demonstration Enterprise for Technological Innovation
Postdoctoral Research Station
Postdoctoral Research Station
Nobel Prize Expert Workstation
Nobel Prize Expert Workstation
Hebei Provincial Engineering Research Center for Large-Volume Injectable Preparations
Hebei Provincial Engineering Research Center for Large-Volume Injectable Preparations
First Prize of the Hebei Provincial Science and Technology Award
First Prize of the Hebei Provincial Science and Technology Award
2021 China’s Best Industrial Enterprise for Pharmaceutical R&D Product Lines
2021 China’s Best Industrial Enterprise for Pharmaceutical R&D Product Lines
Top 50 Chinese Chemical Pharmaceutical R&D Companies in 2019
Top 50 Chinese Chemical Pharmaceutical R&D Companies in 2019
Top 50 Chinese Pharmaceutical R&D Comprehensive Strengths in 2019
Top 50 Chinese Pharmaceutical R&D Comprehensive Strengths in 2019
R&D Institutions of Industrial Enterprises in Hebei Province
R&D Institutions of Industrial Enterprises in Hebei Province
Research Unit Undertaking a Sub-project of the National Major Science and Technology Special Project for New Drug Development
National-Local Joint Engineering Laboratory
National Enterprise Technology Center
National Demonstration Enterprise for Technological Innovation
Postdoctoral Research Station
Nobel Prize Expert Workstation
Hebei Provincial Engineering Research Center for Large-Volume Injectable Preparations
First Prize of the Hebei Provincial Science and Technology Award
2021 China’s Best Industrial Enterprise for Pharmaceutical R&D Product Lines
Top 50 Chinese Chemical Pharmaceutical R&D Companies in 2019
Top 50 Chinese Pharmaceutical R&D Comprehensive Strengths in 2019
R&D Institutions of Industrial Enterprises in Hebei Province

Reasonable and efficient R&D structure

New drug R&D Center
New drug R&D Center
Solid preparations R&D Center
Solid preparations R&D Center
Liquid preparations R&D Center
Liquid preparations R&D Center
APIs R&D Center
APIs R&D Center
Quality inspection department
Quality inspection department
Registration affairs department
Registration affairs department
Patent affairs department
Patent affairs department
Scientific research management department
Scientific research management department
Information project approval department
Information project approval department
Analysis Center
Analysis Center
Medical Center
Medical Center
Technology Transfer Center
Technology Transfer Center

Focus on frontier research of medicine

Team Environment Achievements
Research team

The company gathers international top medical experts, domestic industry senior experts and academic leaders of scientific research institutes, Led by doctors, the scientific research team with all kinds of cutting-edge talents as the backbone focuses on the frontier research of medicine


The high-level professional research teams of synthesis, analysis, preparations and APIs led by doctors and masters have established liquid preparation laboratories, solid preparation laboratories, jointly built laboratories with colleges and universities, and pilot laboratories. It has established high-level innovation platforms such as engineering laboratories and technology research centers jointly with Chinese Academy of Sciences, Zhejiang University, Tianjin University and other colleges and universities, and now has nearly 400 high-level talents in drug research, analysis and clinical research.

First class experimental facilities and beautiful humanistic research environment complement each other

Gas Chromatography Laboratory

Gas Chromatography Laboratory

R&D Experiment

R&D Experiment

R&D Experiment

R&D Experiment

Every year, it has cultivated more than 100 scientific research achievements in the treatment fields of anti-tumor, nervous system and cardiovascular system, as well as a number of national and provincial major scientific and technological innovation and industrialization projects.

Patent Certificate

The products studied mainly involve the treatment fields of respiratory system, neuropsychiatric system, digestive and metabolic system, anti-infection, cardiovascular system, basic infusion (including dialysis and flushing).

A Method for the Preparation of Bromhexine Hydrochloride and Glucose Injection
A Method for the Preparation of Bromhexine Hydrochloride and Glucose Injection
Hydroxyethyl Starch Sodium Chloride Injection and Its Preparation Method
Hydroxyethyl Starch Sodium Chloride Injection and Its Preparation Method
Rosuvastatin Calcium Tablets and Their Preparation Method
Rosuvastatin Calcium Tablets and Their Preparation Method
Combination Cap, Dual-Valve Upright Infusion Bag, and Method for Its Preparation
Combination Cap, Dual-Valve Upright Infusion Bag, and Method for Its Preparation
Coating Composition for Cefuroxime Axetil Solid Dispersion and Its Preparation Method
Coating Composition for Cefuroxime Axetil Solid Dispersion and Its Preparation Method
Cefuroxime Axetil Pharmaceutical Composition and Its Preparation Method
Cefuroxime Axetil Pharmaceutical Composition and Its Preparation Method
A Paracetamol Injection and Its Preparation Method
A Paracetamol Injection and Its Preparation Method
Immediate-Release Formulation of Cefpodoxime Proxetil and Its Preparation Method
Immediate-Release Formulation of Cefpodoxime Proxetil and Its Preparation Method
A Double-Layer Aseptic Soft-Bag Packaging System for Sodium Bicarbonate Injection and Its Preparation Method
A Double-Layer Aseptic Soft-Bag Packaging System for Sodium Bicarbonate Injection and Its Preparation Method
A Sofosbuvir Tablet and Its Preparation Method
A Sofosbuvir Tablet and Its Preparation Method
An amorphous solid formulation of sitagliptin succinate and a method for its preparation
An amorphous solid formulation of sitagliptin succinate and a method for its preparation
An Integrated Infusion Bottle (Bag) with a Suspension Ring and Its Manufacturing Method
An Integrated Infusion Bottle (Bag) with a Suspension Ring and Its Manufacturing Method
A bicarbonate dialysis solution packaged in a double-chamber bag and its preparation method
A bicarbonate dialysis solution packaged in a double-chamber bag and its preparation method
A Cefdinir Capsule and Its Preparation Method
A Cefdinir Capsule and Its Preparation Method
A Water-Washing Purification Method for a Caffeine Intermediate
A Water-Washing Purification Method for a Caffeine Intermediate
(Naphthyridine) Compounds and Pharmaceutical Compositions, and Their Applications
(Naphthyridine) Compounds and Pharmaceutical Compositions, and Their Applications
(Australian) Naphthyridine Compounds and Pharmaceutical Compositions, and Their Applications
(Australian) Naphthyridine Compounds and Pharmaceutical Compositions, and Their Applications
(Japan) Naphthyridine Compounds and Pharmaceutical Compositions, and Their Applications
(Japan) Naphthyridine Compounds and Pharmaceutical Compositions, and Their Applications
A method for the preparation of metronidazole
A method for the preparation of metronidazole
A method for the determination of related substances of arbidol hydrochloride
A method for the determination of related substances of arbidol hydrochloride
A method for the preparation of theophylline sodium salt
A method for the preparation of theophylline sodium salt

Innovative drug development pipeline

Covering areas such as oncology, autoimmune diseases, organ fibrosis, anesthesia and analgesia, and antiviral drugs.

Antineoplastic
Antineoplastic
Autoimmune disease
Autoimmune disease
Organ fibrosis
Organ fibrosis
Anesthetic analgesia
Anesthetic analgesia
Antiviral drugs
Antiviral drugs
Sign the contract

Strategic cooperation with Professor Lu Tao of China Pharmaceutical University to develop new small molecule drugs in the fields of cancer, immunity and other diseases.

Cooperation

Strategic cooperation with Professor He Zhonggui of Shenyang Pharmaceutical University to develop advanced pharmaceutical products and improved new drugs.

Generic drug development

Drug Name Specifications Rank Type
Peritoneal Dialysis Solution (Lactate-G1.5%) 2000ml First to pass the evaluation Consistency
Peritoneal Dialysis Solution (Lactate-G2.5%) 2000ml The second store Consistency
Low-calcium peritoneal dialysis solution (lactate–G1.5%) 2000ml The second store Consistency
Low-calcium peritoneal dialysis solution (lactate–G2.5%) 2000ml The 3rd store Consistency
Mecobalamin Injection 1 ml: 0.5 mg Consistency
Sodium Lactate Ringer's Injection 500ml The second store Consistency
Medium/Long-Chain Fat Emulsion Injection (C8–24Ve) 250 ml (20%) The 3rd store Consistency
Argatroban Injection 2 ml: 10 mg New Category 4
Sorbitol-Mannitol Irrigation Solution 3000ml The second store New Category 3
Compound Electrolyte Injection (II) 500ml The second store New Category 4
Compound Electrolyte Injection (II) 1000ml First in specifications New Category 4
Sodium Acetate Ringer’s Injection 500ml Consistency
Tirofiban Hydrochloride Concentrated Injection Solution 15 ml: 3.75 mg New Category 3
Potassium Chloride Injection 10 ml: 1.5 g The 3rd store Consistency
Tirofiban Hydrochloride and Sodium Chloride Injection 100 ml: 5 mg Consistency
Drug Name Specifications Rank Type
Rosuvastatin Calcium Tablets 5mg New Category 4 with Increased Specifications
Felodipine Extended-Release Tablets 5mg New Category 4
Rosuvastatin Calcium Tablets 10mg New Category 4
Valsartan and Amlodipine Tablets (I) Valsartan 80 mg, amlodipine 5 mg New Category 4
Pentoxifylline Sustained-Release Tablets 400mg The first exclusive New Category 3
Pentoxifylline Injection 5 ml: 0.1 g New Category 3
Urapidil Hydrochloride Injection 5 ml: 25 mg The 3rd store New Category 4
Terbutaline Sulfate Injection 1 ml: 0.5 mg The 3rd store New Category 3
Urapidil Hydrochloride Injection 10 ml: 50 mg The 3rd store New Category 4
Pitavastatin Calcium Tablets 1mg The 3rd store New Category 4
Pitavastatin Calcium Tablets 2mg The 3rd store New Category 4
Metoprolol Tartrate Injection 5 ml: 5 mg The 3rd store Consistency
Drug Name Specifications Rank Type
Prucalopride Succinate Tablets 1mg The 3rd store New Category 4
Prucalopride Succinate Tablets 2mg The 3rd store New Category 4
Lipoic Acid Injection 24 ml: 0.6 g Specification, second company New Category 3
Epalrestat Tablets 50mg New Category 3
Ondansetron Hydrochloride Tablets 4mg The 3rd store New Category 3
Ondansetron Hydrochloride Tablets 8mg The 3rd store New Category 3
Drug Name Specifications Rank Type
Bunanserine Tablets 4mg The first exclusive New Category 4
Lacosamide Tablets 50mg New Category 4
Lacosamide Tablets 100mg New Category 4
Lacosamide Injection 20 ml: 0.2 g New Category 4
Lurasidone Hydrochloride Tablets 40mg New Category 4
Ropivacaine Hydrochloride Injection 10 ml: 100 mg New Category 4
Ropivacaine Hydrochloride Injection 10 ml: 75 mg The 3rd store New Category 4
Paracetamol Mannitol Injection 100 ml: 1000 mg The second store New Category 3
Dexmedetomidine Hydrochloride Injection 2 ml: 0.2 mg New Category 3
Dexmedetomidine Hydrochloride Injection 1 ml: 0.1 mg New Category 3
Citicoline Sodium Injection 4 ml: 0.5 g New Category 3
Stiripentol Dry Suspension 500mg First to pass the evaluation New Category 3
Stiripentol Dry Suspension 250mg First to pass the evaluation New Category 3
Drug Name Specifications Rank Type
Ciprofloxacin Lactate and Sodium Chloride Injection 200 ml: 0.4 g Specification, second company Consistency Enhancement Rules
Fluconazole Sodium Chloride Injection 100 ml: 0.2 g The second store Consistency
Fluconazole Tablets 50mg The second store Consistency
Fluconazole Tablets 150mg First to pass the evaluation Consistency
Metronidazole and Sodium Chloride Injection 100 ml: 0.5 g The second store Consistency
Metronidazole and Sodium Chloride Injection 250 ml: 1.25 g First to pass the evaluation Consistency
Ciprofloxacin Lactate and Sodium Chloride Injection 100 ml: 0.2 g First to pass the evaluation Consistency
Cefaclor Dry Suspension 0.125g Consistency
Moxifloxacin Hydrochloride and Sodium Chloride Injection 250 ml: 0.4 g Consistency
Azithromycin for Injection 0.5g Consistency
Azithromycin Dry Suspension 0.1g First to pass the evaluation New Category 4
Azithromycin Tablets 0.25g New Category 4
Fluconazole Sodium Chloride Injection 50 ml: 0.1 g First to pass the evaluation New Category 4
Linezolid Glucose Injection 100 ml: 0.2 g New Category 4
Cefdinir Capsules 0.1g The 3rd store New Category 4
Moxifloxacin Hydrochloride Tablets 0.4g New Category 4
Levofloxacin Sodium Chloride Injection 100 ml: 0.5 g New Category 4
Ornidazole Injection 3 ml: 0.5 g New Category 3
Ornidazole Injection 6 ml: 1.0 g New Category 3
Levofloxacin Injection 20 ml: 500 mg New Category 3
Ornidazole Injection 6 ml: 1.0 g New Category 3
Metronidazole Tablets 0.2g Consistency
Moxifloxacin Hydrochloride Eye Drops 0.5% (5 mL: 25 mg) New Category 4
Tedizolid Phosphate for Injection 200mg New Category 4
Oseltamivir Phosphate Dry Suspension 0.36g New Category 3
Ornidazole Tablets 0.5g New Category 3
Tinidazole Tablets 0.5g New Category 3
Linezolid Sodium Chloride Injection 300 ml: 0.6 g The 3rd store New Category 3
Drug Name Specifications Rank Type
Ambroxol Hydrochloride Injection 1 ml: 7.5 mg Consistency
Ambroxol Hydrochloride Injection 2 ml: 15 mg Consistency
Ambroxol Hydrochloride Injection 4 ml: 30 mg Consistency
Doxofylline Injection 10 ml: 0.1 g First to pass the evaluation New Category 4
Terbutaline Sulfate Solution for Nebulization 2 ml: 5 mg The second store New Category 4
Ipratropium Bromide Solution for Inhalation 2 ml: 0.5 mg New Category 4
Ipratropium Bromide Solution for Inhalation 1 ml: 0.5 mg The 3rd store New Category 3
Terbutaline Sulfate Injection 1 ml: 0.5 mg The 3rd store New Category 3
Bromhexine Hydrochloride Injection 2 ml: 4 mg The second store New Category 3
Terbutaline Sulfate Solution for Nebulization 1 ml: 2.5 mg Specification, second company Consistency Enhancement Rules
Salbutamol Sulfate Injection 1 ml: 0.5 mg The second store New Category 3
Aminophylline Injection 10 ml: 0.25 g New Category 3
Aminophylline Injection 20 ml: 0.5 g New Category 3
Drug Name Specifications Rank Type
Cinacalcet Hydrochloride Tablets 25mg New Category 4

Generic drug development dosage forms

Diversification of dosage forms for injectable pharmaceutical products

★ Liposome and microsphere formulations

★ Injectable Emulsion

★ Dedicated Formulation

★ Freeze-dried formulation

★ Hormonal Injections

★ Large-volume injectables

01
Diversification of Oral Dosage Forms

★ Regular Tablets

★ Controlled-Release Tablets

★ Compound Preparations

★ Capsule

★ Single-dose dry suspension

★ Multi-dose dry suspension

02
Diversification of dosage forms for other pharmaceutical products

★ Inhalation Preparations

★ Single-dose eye drops

★ Dialysate

★ Irrigation Solution

03

Lead the future by innovation

SSY Group Limited aims to become one of the “first echelon of pharmaceutical innovation” companies. It continuously strengthens innovation-driven development; it vigorously encourages the integration of production and research, strengthens and optimizes the five domains:new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs; and it promotes the cause of human health with strength from China!